Clinical Trials Browser

Phase 3 × Neoplasms, Squamous Cell × zalutumumab × Clear all

NCT00382031 2013-10-15

Zalutumumab in Patients With Non-curable Head and Neck Cancer

Phase 3 Completed

286 enrolled 12 charts

Head and Neck Neoplasms, Neoplasms, Squamous Cell